Aurinia Pharm Ord
(AUPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -88,385 | -64,120 | -70,792 | -23,295 | -18,607 |
| Depreciation Amortization | 1,171 | 1,447 | 1,338 | 1,311 | 1,340 |
| Accounts receivable | -151 | -108 | -23 | -39 | 45 |
| Other Working Capital | 2,029 | -6,000 | 1,699 | 1,470 | 1,221 |
| Other Operating Activity | 21,751 | 17,171 | 26,609 | 1,840 | -1,765 |
| Operating Cash Flow | $-63,585 | $-51,610 | $-41,169 | $-18,713 | $-17,766 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,884 | 9 | -7,978 | -21,119 | 27 |
| PPE Investments | -101 | -75 | -25 | 31,110 | -50 |
| Investing Cash Flow | $7,783 | $-66 | $-8,003 | $9,991 | $-23 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 243,854 | 4,014 | 166,468 | 9,833 | 839 |
| Other Financing Activity | 0 | 0 | 8,684 | 32,782 | 0 |
| Financing Cash Flow | $243,854 | $4,014 | $175,152 | $42,615 | $839 |
| Beginning Cash Position | 117,967 | 165,629 | 39,649 | 5,756 | 22,706 |
| End Cash Position | 306,019 | 117,967 | 165,629 | 39,649 | 5,756 |
| Net Cash Flow | $188,052 | $-47,662 | $125,980 | $33,893 | $-16,950 |
| Free Cash Flow | |||||
| Operating Cash Flow | -63,585 | -51,610 | -41,169 | -18,713 | -17,766 |
| Capital Expenditure | -101 | -75 | -25 | -25 | -50 |
| Free Cash Flow | -63,686 | -51,685 | -41,194 | -18,738 | -17,816 |